EcoDrugPlus

Epidermal Growth Factor Receptor

Ensembl ID : ENSJJAG00000014249
Gene Symbol: EGFR
3 Cross references
285 Possible Orthologues:

Epoxide Hydrolase 2

Ensembl ID : ENSJJAG00000021412
Gene Symbol: EPHX2
3 Cross references
203 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 2

Ensembl ID : ENSJJAG00000004797
Gene Symbol: ERBB2
3 Cross references
200 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 3

Ensembl ID : ENSJJAG00000021056
Gene Symbol: ERBB3
3 Cross references
282 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 4

Ensembl ID : ENSJJAG00000021464
Gene Symbol: ERBB4
3 Cross references
236 Possible Orthologues:

Estrogen Receptor 2

Ensembl ID : ENSJJAG00000018103
Gene Symbol: ESR2
3 Cross references
273 Possible Orthologues:

Estrogen Related Receptor Gamma

Ensembl ID : ENSJJAG00000012656
Gene Symbol: ESRRG
3 Cross references
277 Possible Orthologues:

Exportin 1

Ensembl ID : ENSJJAG00000020468
Gene Symbol: XPO1
3 Cross references
304 Possible Orthologues:

Farnesyl Pyrophosphate Synthase Pseudogene

Ensembl ID : ENSJJAG00000018522
Gene Symbol: LOC101612095
1 Cross references
265 Possible Orthologues:

Farnesyl-Diphosphate Farnesyltransferase 1

Ensembl ID : ENSJJAG00000018680
Gene Symbol: FDFT1
3 Cross references
215 Possible Orthologues:

Farnesyltransferase, Caax Box, Alpha

Ensembl ID : ENSJJAG00000010498
Gene Symbol: FNTA
3 Cross references
221 Possible Orthologues:

Fatty Acid Amide Hydrolase

Ensembl ID : ENSJJAG00000005088
Gene Symbol: FAAH
3 Cross references
131 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).